Doctor profile · Federal record
Dr. Saurin Mehta, MD
Specialist (CMS: Rheumatology) · Wyomissing, PA
- NPI 1245394295
- Accepts Medicare
- MIPS 86.8 / 100 · 2023
- 23 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2760 Century Blvd
Wyomissing, PA 196103359
(610) 375-4251
fax (610) 375-6210
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- July 12, 2010
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Pennsylvania #MD428558
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1245394295. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
331,848
Distinct HCPCS
10
Medicare allowed
$3,274,215
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 156,244 | 54 | $6 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 85,200 | 46 | $5 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 28,770 | 32 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 22,020 | 252 | $23 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 16,749 | 26 | $12 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,175 | 26 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 5,130 | 29 | $31 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,214 | 178 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 812 | 482 | $122 | |
96372 |
Injection of drug or substance under skin or into muscle | 773 | 285 | $14 |
In context: peer comparison
Among 2 peers in Wyomissing Specialist, average services per provider: 4,475. This provider delivers 74× the peer median.Open Payments
Industry payments received
All-time total
$1,263
Transactions
62
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 10 | $221.18 | |
| Amgen INC. | 12 | $200.00 | |
| Abbvie INC. | 14 | $198.94 | |
| GlaxoSmithKline, LLC. | 7 | $135.56 | |
| Janssen Biotech, INC. | 2 | $106.97 | |
| Ucb, INC. | 3 | $99.69 | |
| Novartis Pharmaceuticals Corporation | 4 | $85.58 | |
| Lilly USA, LLC | 3 | $62.72 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $55.55 | |
| Genzyme Corporation | 2 | $52.02 | |
| Pfizer INC. | 1 | $23.49 | |
| Sandoz INC. | 1 | $21.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,561
Patients
686
Total drug cost
$315,875
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 446 | 105 | $6,686 |
| Methotrexate (Methotrexate Sodium) | Brand | 389 | 99 | $16,496 |
| Hydroxychloroquine Sulfate | Generic | 321 | 81 | $19,209 |
| Tramadol Hcl | Generic | 261 | 57 | $4,154 |
| Alendronate Sodium | Generic | 256 | 97 | $3,493 |
| Gabapentin | Generic | 178 | 54 | $3,924 |
| Allopurinol | Generic | 175 | 35 | $2,807 |
| Duloxetine Hcl | Generic | 139 | 40 | $2,767 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 123 | 41 | $4,259 |
| Colchicine | Generic | 56 | 11 | $4,601 |
Hospital affiliations
Frequently asked questions
What is Dr. Saurin Mehta's medical specialty?
Dr. Saurin Mehta practices Specialist in Wyomissing, PA.
Where does Dr. Saurin Mehta practice?
Dr. Saurin Mehta practices at 2760 Century Blvd, Wyomissing, PA 196103359. Office phone: 6103754251.
What is Dr. Saurin Mehta's NPI?
Dr. Saurin Mehta's National Provider Identifier (NPI) is 1245394295, issued by NPPES.
Does Dr. Saurin Mehta accept Medicare assignment?
Yes. Dr. Saurin Mehta accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Saurin Mehta commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111). Source: CMS Medicare Physician & Other Practitioners file.